Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro

Journal of Pathology

Volumn 227, Issue 2, 2012, Pages 175-188

  Meng, Xiao Ming ^a   Huang, Xiao Ru ^a   Xiao, Jun ^a   Chen, Hai Yong ^a   Zhong, Xiang ^a   Chung, Arthur C K ^a   Lan, Hui Yao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

renal fibrosis; renal inflammation; Smad; TGF receptor II

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD ANCHOR FOR RECEPTOR ACTIVATION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; MALE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FIBROSIS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; KIDNEY; KIDNEY TUBULES; MICE; MICE, KNOCKOUT; NEPHRITIS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84862785580     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3976     Document Type: Article

References (39)

1. Bottinger EP, Bitzer M,. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610.
2. Schnaper HW, Hayashida T, Poncelet AC,. It's a Smad world: regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 2002; 13: 1126-1128.
3. Wang W, Koka V, Lan HY,. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005; 10: 48-56.
4. Kopp JB, Factor VM, Mozes M, et al., Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003.
5. Letterio JJ, Roberts AB,. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-161.
6. Kulkarni AB, Huh CG, Becker D, et al., Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993; 90: 770-774.
7. Huang XR, Chung AC, Wang XJ, et al., Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. Am J Physiol Renal Physiol 2008; 295: F118-F127.
8. Wang W, Huang XR, Li AG, et al., Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005; 16: 1371-1383.
9. Huang XR, Chung AC, Zhou L, et al., Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol 2008; 19: 233-242.
10. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584.
11. Massague J, Wotton D,. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000; 19: 1745-1754.
12. Sato M, Muragaki Y, Saika S, et al., Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486-1494.
13. Meng XM, Huang XR, Chung AC, et al., Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol 2010; 21: 1477-1487.
14. Chung AC, Huang XR, Zhou L, et al., Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 2009; 24: 1443-1454.
15. Inazaki K, Kanamaru Y, Kojima Y, et al., Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 2004; 66: 597-604.
16. Huang XR, Chung AC, Yang F, et al., Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 2010; 55: 1165-1171.
17. Hou CC, Wang W, Huang XR, et al., Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 2005; 166: 761-771.
18. Lan HY, Mu W, Tomita N, et al., Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14: 1535-1548.
19. Ng YY, Hou CC, Wang W, et al., Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl 2005; S83-S91.
20. Ka SM, Huang XR, Lan HY, et al., Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 2007; 18: 1777-1788.
21. Chen HY, Huang XR, Wang W, et al., The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 2011; 60: 590-601.
22. Oshima M, Oshima H, Taketo MM,. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996; 179: 297-302.
23. Shao X, Somlo S, Igarashi P,. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 2002; 13: 1837-1846.
24. Leveen P, Larsson J, Ehinger M, et al., Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002; 100: 560-568.
25. Fu P, Liu F, Su S, et al., Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol 2006; 17: 3105-3114.
26. Wang W, Huang XR, Canlas E, et al., Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 2006; 98: 1032-1039.
27. Chung AC, Zhang H, Kong YZ, et al., Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. J Am Soc Nephrol 2010; 21: 249-260.
28. Lan HY, Mu W, Nikolic-Paterson DJ, et al., A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 1995; 43: 97-102.
29. Dennler S, Itoh S, Vivien D, et al., Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998; 17: 3091-3100.
30. Medina C, Santos-Martinez MJ, Santana A, et al., Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis. J Pathol 2011; 224: 461-472.
31. Li M, Krishnaveni MS, Li C, et al., Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J Clin Invest 2011; 121: 277-287.
32. Anumanthan G, Tanaka ST, Adams CM, et al., Bladder stromal loss of transforming growth factor receptor II decreases fibrosis after bladder obstruction. J Urol 2009; 182: 1775-1780.
33. Denton CP, Zheng B, Evans LA, et al., Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J Biol Chem 2003; 278: 25109-25119.
34. Song CY, Kim BC, Hong HK, et al., TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis. Kidney Int 2007; 71: 882-888.
35. Gewin L, Bulus N, Mernaugh G, et al., TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis. J Am Soc Nephrol 2010; 21: 1334-1343.
36. Pat B, Yang T, Kong C, et al., Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 2005; 67: 931-943.
37. Wu WP, Chang CH, Chiu YT, et al., A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren. Am J Physiol Renal Physiol 2010; 299: F929-F941.
38. Li MO, Sanjabi S, Flavell RA,. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006; 25: 455-471.
39. Zhang F, Tsai S, Kato K, et al., Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem 2009; 284: 17564-17574.